Your browser doesn't support javascript.
loading
Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.
Cao, Ming; Gu, Zhu-Qin; Li, Yuan; Zhang, Hui; Dan, Xiao-Juan; Cen, Shan-Shan; Li, Da-Wei; Chan, Piu.
Affiliation
  • Cao M; Department of Neurobiology, Neurology and Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.
  • Gu ZQ; Parkinson Disease Center of Beijing Institute of Brain Disorders, Beijing, 100053, China.
  • Li Y; Beijing Key Laboratory on Parkinson's Disease, Beijing, 100053, China.
  • Zhang H; Department of Neurobiology, Neurology and Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.
  • Dan XJ; Beijing Key Laboratory on Parkinson's Disease, Beijing, 100053, China.
  • Cen SS; Department of Neurobiology, Neurology and Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.
  • Li DW; Beijing Key Laboratory on Parkinson's Disease, Beijing, 100053, China.
  • Chan P; Department of Neurobiology, Neurology and Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.
Neurosci Bull ; 32(6): 572-576, 2016 Dec.
Article in En | MEDLINE | ID: mdl-27699718
ABSTRACT
Olfactory dysfunction has been reported in Parkinson's disease (PD) patients carrying the LRRK2 G2019S variant in Caucasians but rarely in those with the LRRK2 G2385R variant. In this study, we performed genotyping for the LRRK2 G2385R variant in PD patients recruited from the Movement Disorder Clinic of Xuanwu Hospital in Beijing and in healthy controls randomly selected from the Beijing Longitudinal Study on Aging cohort. The "five-odor olfactory detection array", an olfactory threshold test, was used to assess olfactory function. One hundred and eighty-six participants were enrolled, comprising 43 PD patients without (iPD) and 25 with (LRRK2-PD) the LRRK2 G2385R variant, and 118 healthy controls. Our results showed that the threshold of olfactory identification was significantly worse in PD patients than in controls, but not significantly different between the iPD and LRRK2-PD groups. These findings suggested that although olfactory function in LRRK2-PD patients is impaired, it is similar to that in iPD patients.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Polymorphism, Single Nucleotide / Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / Olfaction Disorders Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurosci Bull Journal subject: NEUROLOGIA Year: 2016 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Polymorphism, Single Nucleotide / Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / Olfaction Disorders Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurosci Bull Journal subject: NEUROLOGIA Year: 2016 Document type: Article Affiliation country: China